Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: CRXX-Combinatorx

No earlier versions found for this Subject.

Return to CRXX-Combinatorx

combinatorx.com

BOSTON, Nov 09, 2005 (BUSINESS WIRE) -- CombinatoRx, Incorporated (Nasdaq: CRXX) today announced the pricing of its initial public offering of 6,000,000 shares of its common stock at $7.00 per share, before underwriting discounts and commissions. All of the common stock is being offered by CombinatoRx. In addition, CombinatoRx has granted the underwriters an option to purchase up to an additional 900,000 shares to cover over-allotments, if any. SG Cowen & Co., LLC is acting as sole book-running manager, Pacific Growth Equities, LLC is acting as co-lead manager, and Lazard Capital Markets and A.G. Edwards are acting as co-managers for the offering. CombinatoRx's common stock is expected to be accepted for quotation on the NASDAQ National Market on November 9, 2005 under the symbol "CRXX."